<code id='022CD714F9'></code><style id='022CD714F9'></style>

<acronym id='022CD714F9'></acronym>

<center id='022CD714F9'><center id='022CD714F9'><tfoot id='022CD714F9'></tfoot></center><abbr id='022CD714F9'><dir id='022CD714F9'><tfoot id='022CD714F9'></tfoot><noframes id='022CD714F9'>

<optgroup id='022CD714F9'><strike id='022CD714F9'><sup id='022CD714F9'></sup></strike><code id='022CD714F9'></code></optgroup>

<b id='022CD714F9'><label id='022CD714F9'><select id='022CD714F9'><dt id='022CD714F9'><span id='022CD714F9'></span></dt></select></label></b><u id='022CD714F9'></u>

~~<i id='022CD714F9'><strike id='022CD714F9'><tt id='022CD714F9'><pre id='022CD714F9'></pre></tt></strike></i>~~

Home» knowledge» entertainment

entertainment

entertainment

author：hotspot 2025-09-06 05:55:24 Page View：52759

An FDA sign — health policy coverage from STAT — Sarah Silbiger/Getty Images

WASHINGTON — There’s about to be a new acronym in town.

The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

advertisement

That overhaul includes a new name: Meet the Office of Inspections and Investigations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Studies point to risks of excluding people with obesity from drug trials
Next article： Continuity nursing helped my family in our darkest PICU moments

Wikipedia

The cancer drug shortage isn’t new — and neither are the solutions

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

How climate

How climate

AdobeIn2003,duringEurope’sworstheatwaveincenturies,almost15,000peoplediedinFrance.Aboutthree-quarter

Moonlake's readout produced a cash windfall. Risks remain

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

STAT Summit: Biotech founders on deal

Fromleft,EliLilly'sJacobS.VanNaarden,Avenzo'sAthenaCountouriotis,andBiohaven'sVladCoriconstageatthe2

read more